Anlon Healthcare Clarifies Share Swap Pricing for Apiqo & Bizotic Acquisition
Anlon Healthcare Ltd has issued an additional disclosure regarding the share swap for its acquisitions of Apiqo Organics Private Limited (44.94%) and Bizotic Lifescience Private Limited (47.41%). This clarification follows the approval of the share swap at the 13th Annual General Meeting held on September 5, 2026. The company has revised the 'Basis or justification for the price' section of the AGM Notice, detailing the pricing mechanism for the preferential issue. The floor price has been determined as Rs. 17.85 per equity share, based on the volume-weighted average price on NSE over 90 trading days preceding the relevant date, in accordance with SEBI ICDR Regulations. The company has obtained revised valuation reports from CA Gaurang Agarwal.
Key Highlights
- Anlon Healthcare clarifies share swap pricing for acquisitions.
- Share swap for Apiqo and Bizotic acquisitions approved by shareholders.
- Floor price for preferential issue set at Rs. 17.85 per share.
- Pricing determined by SEBI ICDR Regulations and valuation reports.
- Disclosure aims to maintain corporate governance standards.
Price Impact
More from AHCL